Blocking TIM-3 checkpoint molecule promotes antitumor immune response in diffuse intrinsic stem glioma
Researchers from Cima and the Clínica Universidad de Navarra, together with the international cooperative group Diffuse Midline Glioma (DMG-ACT), have confirmed that blocking an immune checkpoint molecule reduces the tumor…